Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.

× No keyword cloud information.

13 in total

Review 1. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors: Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal: Biochim Biophys Acta Date: 2009-01-22

2. PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?

Authors: Meaghan L Barr; Lucia B Jilaveanu; Robert L Camp; Adebowale J Adeniran; Harriet M Kluger; Brian Shuch
Journal: J Clin Pathol Date: 2014-10-14 Impact factor: 3.411

3. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.

Authors: B-R Kim; E-K Yang; D-Y Kim; S-H Kim; D-C Moon; J-H Lee; H-J Kim; J-C Lee
Journal: Clin Exp Immunol Date: 2012-01 Impact factor: 4.330

Review 4. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Authors: Egesta Lopci; Ilaria Grassi; Arturo Chiti; Cristina Nanni; Gianfranco Cicoria; Luca Toschi; Cristina Fonti; Filippo Lodi; Sandro Mattioli; Stefano Fanti
Journal: Am J Nucl Med Mol Imaging Date: 2014-06-07

5. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.

Authors: Adeboye O Osunkoya; Qiqin Yin-Goen; John H Phan; Richard A Moffitt; Todd H Stokes; May D Wang; Andrew N Young
Journal: Hum Pathol Date: 2009-08-19 Impact factor: 3.466

10. Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions.

Authors: Tobias C Wind; Michael P Messenger; Douglas Thompson; Peter J Selby; Rosamonde E Banks
Journal: Ann Clin Biochem Date: 2011-03-02 Impact factor: 2.057

Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.

Review 1. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

2. PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?

3. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.

Review 4. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

5. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.

Review 6. The role of the systemic inflammatory response as a biomarker in immunotherapy for renal cell cancer.

Review 7. Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma.

8. Role of CAIX Expression in Conventional Renal Cell Carcinomas as a Diagnostic Marker and its Prognostic Importance.

Review 9. Positron emission tomography in renal cell carcinoma: an imaging biomarker in development.

10. Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions.